Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer

[1]  R. Vadlamudi,et al.  Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis , 2015, Development.

[2]  M. Bentires-Alj,et al.  How pregnancy at early age protects against breast cancer. , 2014, Trends in molecular medicine.

[3]  Piotr J. Balwierz,et al.  Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium , 2013, Breast Cancer Research.

[4]  R. Lidereau,et al.  Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO) , 2012, Breast Cancer Research.

[5]  J. Palmer,et al.  Parity and Lactation in Relation to Estrogen Receptor Negative Breast Cancer in African American Women , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[6]  A. González-Angulo,et al.  Triple‐negative breast cancer in Hispanic patients , 2011, Cancer.

[7]  G. Hortobagyi,et al.  Higher parity and shorter breastfeeding duration , 2010, Cancer.

[8]  Ivar Heuch,et al.  Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway , 2010, BMC Cancer.

[9]  P. Furth,et al.  Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. , 2010, Cancer research.

[10]  Baocun Sun,et al.  ORIGINAL ARTICLE: The Effect of High Gravidity on the Carcinogenesis of Mammary Gland in TA2 Mice , 2010, American journal of reproductive immunology.

[11]  Baocun Sun,et al.  Identification of Metastasis-Related Proteins and Their Clinical Relevance to Triple-Negative Human Breast Cancer , 2008, Clinical Cancer Research.

[12]  A. Ashworth,et al.  Pregnancy and the risk of breast cancer. , 2007, Endocrine-related cancer.

[13]  M. Wicha,et al.  Mammary stem cell number as a determinate of breast cancer risk , 2007, Breast Cancer Research.

[14]  Baocun Sun,et al.  Clusterin Expression and Univariate Analysis of Overall Survival in Human Breast Cancer , 2006, Technology in cancer research & treatment.

[15]  A. Kornblihtt,et al.  Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells , 2005, Molecular and Cellular Biology.

[16]  S. Kamal,et al.  Risk factors for breast cancer in Pakistani women aged less than 45 years , 2004, Annals of human biology.

[17]  R. Clarke.  Human breast cell proliferation and its relationship to steroid receptor expression , 2004, Climacteric : the journal of the International Menopause Society.

[18]  E. Garrido,et al.  Bcl-2 protein in normal, hyperplastic and neoplastic breast tissues. A metabolite of the putative stem-cell subpopulation of the mammary gland. , 2004, Histology and histopathology.

[19]  J. Visvader,et al.  Transcriptional regulators in mammary gland development and cancer. , 2003, The international journal of biochemistry & cell biology.

[20]  J. Palmer,et al.  Dual effect of parity on breast cancer risk in African-American women. , 2003, Journal of the National Cancer Institute.

[21]  M. Gross,et al.  Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol. , 2001, Carcinogenesis.

[22]  R. Kumar,et al.  Apoptosis in mammary gland and cancer. , 2000, Endocrine-related cancer.

[23]  Y. Chiew,et al.  Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  William Rostène,et al.  Hormonal regulation of apoptosis in breast cells and tissues , 2000, Steroids.

[25]  D. Trichopoulos,et al.  Low oestrogen receptor α expression in normal breast tissue underlies low breast cancer incidence in Japan , 1999, The Lancet.

[26]  R. Guzman,et al.  Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Borner,et al.  Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c , 1998, Nature.

[28]  T. McDonnell,et al.  Cell death signal transduction and Bcl-2 function. , 1996, Biochemical Society transactions.

[29]  John Calvin Reed.  Balancing cell life and death: bax, apoptosis, and breast cancer. , 1996, The Journal of clinical investigation.

[30]  J. Russo,et al.  Toward a physiological approach to breast cancer prevention. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  Baocun Sun,et al.  Effects of FGF-1 and FGFR1 on the Genesis of Spontaneous Breast Cancer in TA2 Mice , 2009 .

[32]  S. Bao-cun.  Pathologic characteristic of spontaneous breast cancer in TAII mice , 2007 .

[33]  H. Olsson,et al.  Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors , 2005, Breast Cancer Research and Treatment.

[34]  P. Unterberger,et al.  Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History , 2004, Breast Cancer Research and Treatment.